Tromboflebitis portal secundaria a abscesos hepáticos por Gemella morbillorum

Rodríguez Framil, Montserrat; Martínez de Rituerto, Santiago Tomé; Otero Antón, Esteban; Lado Lado, Francisco.
Gastroenterol. hepatol. (Ed. impr.) ; 33(2): 149-150, feb. 2010.
Artículo en Español | IBECS (España) | ID: ibc-80124

Documentos relacionados

  1. Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients.
  2. Population Pharmacokinetic Modeling of Total and Free Ceftriaxone in Critically Ill Children and Young Adults and Monte Carlo Simulations Support Twice Daily Dosing for Target Attainment.
  3. Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority Study.
  4. Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model.
  5. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
  6. Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination.
  7. Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults.
  8. Combined Effect of Ceftriaxon and Low-Frequency Ultrasound on the Viability of Staphylococcus epidermidis Cells in a Preformed Biofilm.
  9. Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients-a population pharmacokinetic study.
  10. Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients.